Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Garg

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Journal of the Indian Medical Association|October 1, 1983
IMA: its origin, role and prospectsM G Garg
Journal of the Indian Medical Association|December 1, 1988
Indian Medical Association: an organisationM G Garg
Journal of Medicinal Chemistry|March 1, 1971
Anti-Trichinella spiralis activity of some 1-carbamoyl-3-methyl-2-pyrazolin-4,5-dione 4-arylhydrazonesH G Garg
Journal of Medicinal Chemistry|April 1, 1972
Central nervous system, antidiuretic, and some other activities of pyrazolesH G Garg
World Medical Journal|June 10, 1983
Health care manpower in India: current status and deploymentM G Garg
Journal of Clinical Pathology|January 29, 2005
Cytoplasmic fragments of leukaemic cells masquerading as platelets in an automated haematology analyserN Kakkar, G Garg
Journal of Pharmaceutical Sciences|January 1, 1972
Chemistry and biological activity of N 1 -acyl-4-arylazopyrazolesH G Garg, V Arora
Journal of Medicinal Chemistry|April 1, 1972
Potential antidiabetics. 11. Preparation of 4-arylazo-3,5-disubstituted-(2H)-1,2,6-thiadiazine 1,1-dioxidesH G Garg, C Prakash
Journal of Pharmaceutical Sciences|June 1, 1972
Potential antidiabetics. XII. N- 1 -phenylcarbamoyl-4-arylazo(3- and-or 5-substituted) pyrazoles and their biological activitiesH G Garg, C Prakash
Journal of Pharmaceutical Sciences|February 1, 1971
Potential antidiabetics. 8. 4-Arylhydrazono-N'-guanylnitrate-3-methyl-2-pyrazolin-5-ones, 4-arylazo-N'-guanylnitrate-3,5-dimethylpyrazoles, and 4-arylazo-N'-guanylnitrate-3,5-diphenylpyrazolesH G Garg, C Prakash
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Journal of the Indian Medical Association|October 1, 1983
IMA: its origin, role and prospectsM G Garg
Journal of the Indian Medical Association|December 1, 1988
Indian Medical Association: an organisationM G Garg
Journal of Medicinal Chemistry|March 1, 1971
Anti-Trichinella spiralis activity of some 1-carbamoyl-3-methyl-2-pyrazolin-4,5-dione 4-arylhydrazonesH G Garg
Journal of Medicinal Chemistry|April 1, 1972
Central nervous system, antidiuretic, and some other activities of pyrazolesH G Garg
World Medical Journal|June 10, 1983
Health care manpower in India: current status and deploymentM G Garg
Journal of Clinical Pathology|January 29, 2005
Cytoplasmic fragments of leukaemic cells masquerading as platelets in an automated haematology analyserN Kakkar, G Garg
Journal of Pharmaceutical Sciences|January 1, 1972
Chemistry and biological activity of N 1 -acyl-4-arylazopyrazolesH G Garg, V Arora
Journal of Medicinal Chemistry|April 1, 1972
Potential antidiabetics. 11. Preparation of 4-arylazo-3,5-disubstituted-(2H)-1,2,6-thiadiazine 1,1-dioxidesH G Garg, C Prakash
Journal of Pharmaceutical Sciences|June 1, 1972
Potential antidiabetics. XII. N- 1 -phenylcarbamoyl-4-arylazo(3- and-or 5-substituted) pyrazoles and their biological activitiesH G Garg, C Prakash
Journal of Pharmaceutical Sciences|February 1, 1971
Potential antidiabetics. 8. 4-Arylhydrazono-N'-guanylnitrate-3-methyl-2-pyrazolin-5-ones, 4-arylazo-N'-guanylnitrate-3,5-dimethylpyrazoles, and 4-arylazo-N'-guanylnitrate-3,5-diphenylpyrazolesH G Garg, C Prakash
Pageof 17